Runt-related transcription factor 3 methylation as a possible prognosticator in muscle-invasive bladder cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Biomarkers

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/CBM-2012-0248PMID 22699781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of RUNX3 expression in human melanoma

  2011cited by this paper
• EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

  2011cited by this paper
• Downregulation of runt‐related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland

  2011cited by this paper
• Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300.

  2011cited by this paper
• Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.

  2011cited by this paper
• Role of p53 gene polymorphism and bladder cancer predisposition in northern India

  2010cited by this paper
• Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer

  2010cited by this paper
• Treatment and outcome in muscle invasive bladder cancer: a population-based survey

  2010cited by this paper
• Loss of RUNX3 Expression Correlates with Differentiation, Nodal Metastasis, and Poor Prognosis of Gastric Cancer

  2009cited by this paper
• Runx3 expression in gastrointestinal tract epithelium: resolving the controversy

  2009cited by this paper
• The updated EAU guidelines on muscle-invasive and metastatic bladder cancer.

  2009cited by this paper
• EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

  2008cited by this paper
• Predicting survival after radical cystectomy for bladder cancer

  2008cited by this paper
• Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.

  2008influential reference
• The epigenomics of cancer.

  2007cited by this paper
• Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation.

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006cited by this paper
• RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

  2006cited by this paper
• Urothelial tumorigenesis: a tale of divergent pathways

  2005cited by this paper
• Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

  2005cited by this paper
• RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

  2005cited by this paper
• Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.

  2005cited by this paper
• Oncogenic potential of the RUNX gene family: ‘Overview’

  2004cited by this paper
• Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

  2004cited by this paper
• Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines

  2003cited by this paper
• Bladder cancer.

  2003cited by this paper
• Causal relationship between the loss of RUNX3 expression and gastric cancer.

  2002cited by this paper
• The American Joint Committee on Cancer: updating the strategies in cancer staging.

  2002cited by this paper
• Bladder cancer.

  1998cited by this paper

• A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer

  2021cites this paper
• Developing Biomarkers and New Therapeutic Targets in Muscle Invasive Bladder Cancer

  2020cites this paper
• Prognostic value of DNA methylation for bladder cancer.

  2018cites this paper
• The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review.

  2017cites this paper
• Title : The Prognostic Role of Epigenetic dysregulation in Bladder Cancer : A Systematic Review

  2017cites this paper
• Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study.

  2013cites this paper